Science Explorer Back to mapMap
Discussion
Company · Tarrytown · United States

Araim Pharmaceuticals (United States)

araimpharma.comROR OpenAlex
Research works
28
▼ 91% vs 2018-21
Citations
767
27.3 per fractional work
Top-10% rate
2.9%
all institutions 10.0%
Open access
57%
world 40%
International
58%
world 18%
Araim Pharmaceuticals (United States)

Not ranked overall: Araim Pharmaceuticals (United States) is under the volume floor below which a citation excellence rate is noise. Not ranked is not the same as ranked last.

Which fields of science does Araim Pharmaceuticals (United States) work in?

In all years, 64% of research at Araim Pharmaceuticals (United States) is in Health Sciences, 20% in Life Sciences. Its largest fields are Medicine (63%), Biochemistry, Genetics and Molecular Biology (9%), Immunology and Microbiology (5%). It does 2.2× the world's share of Health Sciences.

Health Sciences: 18 fractional works · 64.0% of its workMedicine: 18 fractional works · 63.0% of its workHematology: 5 fractional works · 19.4% of its workPhysiology: 4 fractional works · 12.8% of its workOncology: 1 fractional works · 5.1% of its workSurgery: 1 fractional works · 4.3% of its workOphthalmology: 1 fractional works · 3.1% of its workPharmacology: 1 fractional works · 2.5% of its workRadiology, Nuclear Medicine and Imaging: 1 fractional works · 2.0% of its workBiochemistry: 1 fractional works · 1.8% of its workRheumatology: 1 fractional works · 1.8% of its workPublic Health, Environmental and Occupational Health: 0 fractional works · 1.3% of its workEndocrinology, Diabetes and Metabolism: 0 fractional works · 1.0% of its workNeurology: 0 fractional works · 1.0% of its workPsychiatry and Mental health: 0 fractional works · 1.0% of its workPathology and Forensic Medicine: 0 fractional works · 0.9% of its workNephrology: 0 fractional works · 0.7% of its workGenetics: 0 fractional works · 0.7% of its workRehabilitation: 0 fractional works · 0.7% of its workDermatology: 0 fractional works · 0.6% of its workEmergency Medicine: 0 fractional works · 0.6% of its workEpidemiology: 0 fractional works · 0.5% of its workPediatrics, Perinatology and Child Health: 0 fractional works · 0.4% of its workTransplantation: 0 fractional works · 0.4% of its workUrology: 0 fractional works · 0.2% of its workHealth Professions: 0 fractional works · 1.0% of its workComplementary and Manual Therapy: 0 fractional works · 0.6% of its workOccupational Therapy: 0 fractional works · 0.4% of its workLife Sciences: 5 fractional works · 19.6% of its workBiochemistry, Genetics and Molecular Biology: 3 fractional works · 9.0% of its workMolecular Biology: 1 fractional works · 3.0% of its workGenetics: 1 fractional works · 1.9% of its workCancer Research: 0 fractional works · 1.8% of its workPhysiology: 0 fractional works · 1.5% of its workCell Biology: 0 fractional works · 0.9% of its workImmunology and Microbiology: 1 fractional works · 5.1% of its workImmunology: 1 fractional works · 5.1% of its workNeuroscience: 1 fractional works · 3.6% of its workNeurology: 1 fractional works · 2.0% of its workCellular and Molecular Neuroscience: 0 fractional works · 1.6% of its workPharmacology, Toxicology and Pharmaceutics: 0 fractional works · 1.4% of its workPharmaceutical Science: 0 fractional works · 1.4% of its workAgricultural and Biological Sciences: 0 fractional works · 0.4% of its workInsect Science: 0 fractional works · 0.2% of its workSmaller subfields together: 0 fractional works · 0.2% of its workPhysical Sciences: 3 fractional works · 9.3% of its workComputer Science: 1 fractional works · 3.6% of its workComputer Vision and Pattern Recognition: 1 fractional works · 3.6% of its workPhysics and Astronomy: 1 fractional works · 3.6% of its workAstronomy and Astrophysics: 1 fractional works · 3.6% of its workMathematics: 0 fractional works · 1.8% of its workTheoretical Computer Science: 0 fractional works · 1.8% of its workEngineering: 0 fractional works · 0.4% of its workBiomedical Engineering: 0 fractional works · 0.3% of its workSmaller subfields together: 0 fractional works · 0.1% of its workSocial Sciences: 2 fractional works · 7.2% of its workEconomics, Econometrics and Finance: 1 fractional works · 3.6% of its workFinance: 1 fractional works · 3.6% of its workSmaller subfields together: 0 fractional works · 0.1% of its workSocial Sciences: 1 fractional works · 2.4% of its workEducation: 1 fractional works · 2.4% of its workArts and Humanities: 0 fractional works · 1.2% of its workPhilosophy: 0 fractional works · 1.2% of its workALL ITS WORKAraimPharmaceuticals…28fractional works, all years
Life Sciences20%Physical Sciences9%Health Sciences64%Social Sciences7%

Each ring splits the one inside it: the four domains of science, their fields, their subfields. Size is fractional works in all years. Every slice is a page; the interactive view zooms down to single topics and colours each by how much more of it this institution does than the world.

Its 4 domains and 14 fields, with their numbers
    1. Medicine1863.0%
    2. Health Professions01.0%
    1. Biochemistry, Genetics and Molecular Biology39.0%
    2. Immunology and Microbiology15.1%
    3. Neuroscience13.6%
    4. Pharmacology, Toxicology and Pharmaceutics01.4%
    5. Agricultural and Biological Sciences00.4%
    1. Computer Science13.6%
    2. Physics and Astronomy13.6%
    3. Mathematics01.8%
    4. Engineering00.4%
    1. Economics, Econometrics and Finance13.6%
    2. Social Sciences12.4%
    3. Arts and Humanities01.2%
All of science, and how each field's share has moved since 1950: the Science domain explorer

Field profile

Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.

Who are the top researchers at Araim Pharmaceuticals (United States)?

Ranked on the quality score, Michael L. Brines and Ann N. Dunne lead among researchers whose main affiliation is Araim Pharmaceuticals (United States).

  1. 1 Michael L. Brines United States · #105,839 worldwide 18k citations · 216 works
  2. 2 Ann N. Dunne United States · #1,469,467 worldwide 643 citations · 16 works
All ranked researchers at Araim Pharmaceuticals (United States)

What are the most cited papers from Araim Pharmaceuticals (United States)?

The most cited paper from Araim Pharmaceuticals (United States) is "Modulation of Renal Disease in MRL/lpr Mice by Suberoylanilide Hydroxamic Acid" (Christopher M. Reilly, Nilamadhab Mishra, Julie M. Miller et al., 2004), with 146 citations. Next come "ARA 290, a Nonerythropoietic Peptide Engineered from Erythropoietin, Improves Metabolic Control and Neuropathic Symptoms in Patients with Type 2 Diabetes" (144) and "The Receptor That Tames the Innate Immune Response" (137).

Most cited papers
#PaperReleasedCitations
1 Modulation of Renal Disease in MRL/lpr Mice by Suberoylanilide Hydroxamic Acid Christopher M. Reilly, Nilamadhab Mishra, Julie M. Miller et al. · The Journal of Immunology Open access Sep 2004 146
2 ARA 290, a Nonerythropoietic Peptide Engineered from Erythropoietin, Improves Metabolic Control and Neuropathic Symptoms in Patients with Type 2 Diabetes Michael L. Brines, Ann N. Dunne, Monique van Velzen et al. · Molecular Medicine Open access 2014 144
3 The Receptor That Tames the Innate Immune Response Michael L. Brines, Anthony Cerami · Molecular Medicine Open access 15 Dec 2011 137
4 Early nerve fibre regeneration in individuals with type 1 diabetes after simultaneous pancreas and kidney transplantation Shazli Azmi, Maria Jeziorska, Maryam Ferdousi et al. · Diabetologia Open access 7 Jun 2019 122
5 Intervention With an Erythropoietin-Derived Peptide Protects Against Neuroglial and Vascular Degeneration During Diabetic Retinopathy Carmel McVicar, Ross W. Hamilton, Liza M. Colhoun et al. · Diabetes Open access 13 Sep 2011 114
All 55 most cited papers, with filters and sorting

Which keywords describe research at Araim Pharmaceuticals (United States)?

By fractional works in all years, weighted toward what it does more of than the world: Neuroprotection, Anemia, Cardiovascular Disease, Chronic Kidney Disease, Cancer Treatment, Heart Failure, Erythropoiesis-Stimulating Agents and Hypoxia-Inducible Factors.

▲ more of its work than of the world's◆ about the world's share▼ less than the world's

Size is fractional works in all years in the topics tagged with each word; colour is the word's share of this institution's work against its share of the world's. The 27 words are chosen for being large and distinctive. Each links to the topic it comes from most.

All 27 words, with their numbers
  1. Neuroprotection6▲ 58×5 topics
  2. Anemia6▲ 174×3 topics
  3. Cardiovascular Disease5▲ 17×2 topics
  4. Cancer Treatment5▲ 70×2 topics
  5. Chronic Kidney Disease5▲ 74×2 topics
  6. Heart Failure5▲ 40×2 topics
  7. Erythropoiesis-Stimulating Agents5▲ 1209×1 topic
  8. Hypoxia-Inducible Factors5▲ 1209×1 topic
  9. Inflammation2▲ 3.5×11 topics
  10. Oxidative Stress2▲ 3.9×8 topics
  11. Apoptosis2▲ 15×3 topics
  12. Piezo12▲ 120×1 topic
  13. Piezo22▲ 120×1 topic
  14. Biomarkers1▲ 7.8×4 topics
  15. Education1▲ 3.6×2 topics
  16. Epidemiology1◆ 1.13×9 topics
  17. Cell Death1▲ 20×2 topics
  18. BRCA Mutation1▲ 228×1 topic
  19. Cancer Therapy1▲ 6.3×2 topics
  20. Central Sensitization1▲ 54×2 topics
  21. Neuroinflammation1▲ 15×2 topics
  22. PARP Inhibitors1▲ 228×1 topic
  23. Applications1▲ 17×1 topic
  24. Cancer1▲ 2.5×3 topics
  25. ECB's Rescue Facility1▲ 332×1 topic
  26. TARGET2 Balances1▲ 332×1 topic
  27. Technology1▲ 8.2×1 topic

Which research topics does Araim Pharmaceuticals (United States) publish most on?

By volume in 2022-now: Erythropoietin and Anemia Treatment, GDF15 and Related Biomarkers, Chemotherapy-induced organ toxicity mitigation and Acute Kidney Injury Research.

Erythropoietin and Anemi…0Erythropoietin and Anemia Treatment: 0 fractional worksGDF15 and Related Biomar…0GDF15 and Related Biomarkers: 0 fractional worksChemotherapy-induced org…0Chemotherapy-induced organ toxicity mitigation: 0 fractional worksAcute Kidney Injury Rese…0Acute Kidney Injury Research: 0 fractional worksMedicinal Plants and Bio…0Medicinal Plants and Bioactive Compounds: 0 fractional worksNutrition and Health in …0Nutrition and Health in Aging: 0 fractional works
HematologyRheumatologyPathology and Forensic MedicineNephrology2 others

Area is fractional works; colour is the subfield each topic belongs to.

  1. 1 Erythropoietin and Anemia Treatment Hematology 0 works
  2. 2 GDF15 and Related Biomarkers Rheumatology 0 works
  3. 3 Chemotherapy-induced organ toxicity mitigation Pathology and Forensic Medicine 0 works
  4. 4 Acute Kidney Injury Research Nephrology 0 works
  5. 5 Medicinal Plants and Bioactive Compounds Molecular Biology 0 works
  6. 6 Nutrition and Health in Aging Physiology 0 works

How open and international is its research?

Against the world's own shares: the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.

openly available56.9%not open43.1%

World: 40% of research is openly available.

with international co-authors57.9%domestic only42.1%

World: 18% is written across borders.

How has Araim Pharmaceuticals (United States)'s research output changed?

Output in 2022-2025 was 91% lower than in 2018-2021.

still counting20052010201520202025
grewheldshrank

The same series as a ribbon: one cell per year, darker for more. The line above answers how much; this answers when.

Its share of all research

Growing output can still be a shrinking share: all of science grows. This is Araim Pharmaceuticals (United States) as a percentage of every work published that year, 0.0000038% in 2022.

0.000050%0.00010%Araim Pharmaceuticals (United States)0.0000046% in 202320102020

Fractional works of Araim Pharmaceuticals (United States) over all fractional works that year. How the balance of science has shifted.

Other research institutions in Tarrytown

All research institutions in Tarrytown

Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners have tabs of their own, above.

Discussion

Ask a question or share a note about Araim Pharmaceuticals (United States). Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.